← All Sponsors

SPONSOR

University of Texas Southwestern Medical Center

Total Trials

18

Recruiting

18

Phases

Phase 3, Phase 2, EARLY_Phase 1, Phase 4

Conditions studied: Lipid Metabolism Disorder Heart Failure Suicidal Ideation Suicide Attempt Anxiety Depression Disorders Cirrhosis, Liver Healthy Type 1 Hyperlipoprotenemia Postpartum Complication

Multicomponent Intervention Study- Blood Donors With High Cholesterol

Lipid Metabolism Disorder

NCT06349941 Phase 3

Home-based Cardiac Rehabilitation in Heart Failure

Teen Recovery Through Inspiration, Support, and Empowerment

Suicidal Ideation

NCT06015022 Phase 2

EGCG for Hepatocellular Carcinoma Chemoprevention

Cirrhosis, Liver

The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity

NCT05816343 Phase 2

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

Type 1 Hyperlipoprotenemia

IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine

Postpartum Complication

NCT06712745 EARLY_Phase 1

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

Pulmonary Disease

Laryngeal Cryotherapy for Refractory Neurogenic Cough

Upper-Airway Cough Syndrome

Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)

Premature Infants

Outcomes of Focal Ablation for Prostate Cancer

Prostate Cancer

HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

NCT05576974 Phase 2

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Head and Neck Cancer

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

NCT05489523 Phase 4

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation

Transthyretin Cardiac Amyloidosis

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Non-muscle-invasive Bladder Cancer